Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04803448 · ClinicalTrials.gov registry record · NA
Patient Doctor Lies
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 619
- Enrollment target
NCT04803448: Completed NA study, sponsored by University of Utah.
NCT04803448 is a NA study that has completed, run by University of Utah. The registered enrollment target is 619 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04803448, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 619 participants
- Enrollment target
Study Summary
Accurate patient information disclosure is critical to provide optimal treatment. Methods that can detect and then increase the truthfulness of information are relatively unknown. To investigate the impact of communication about privacy, benefits, and risk on patient truthfulness, the investigators test two new methods to detect patient truthfulness and demonstrate the effects of privacy notices (e.g. HIPPA statements). Participants include a national online sample randomly assigned to one of six treatment statements that might be typically given before health information was requested. The assigned treatments include one or mix of the following: privacy notice, statement of the benefits of accurate disclosure, and statement of the risks of inaccurate disclosure and control of no statement before being asked typical health questions. The investigators propose that based on elaboration likelihood model, statements reminding participants of their privacy will increase lying. The investigators hypothesis the use of a new biometric mouse movement lie detection method and answer adjustment can measure patient lies. The investigators hypothesis that reminders of the risk of not telling the truth will reduce lying due to risk aversion. Lastly the investigators hypothesis that statements of benefits of answering truthfully will increase truthfulness.
Primary Outcome
The measure of the distance (mm) the mouse travels to the response.
Interventions
- BEHAVIORAL Benefit statement
- BEHAVIORAL Risk Statement
- BEHAVIORAL Privacy Statement
- BEHAVIORAL Benefit + Privacy
- BEHAVIORAL Risk + Privacy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 619 participants |
| Start Date | 2020-02-12 |
| Est. Completion | 2020-04-19 |
| Phase | NA |
What the finished NCT04803448 record still lists
NCT04803448 is an interventional study that assigns participants to a tested intervention. The registered 619 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower).
The record links to 0 conditions, and to 5 interventions - of which Benefit statement is the first listed.
NCT04803448 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04803448 about?
NCT04803448 is a clinical study titled "Patient Doctor Lies". Accurate patient information disclosure is critical to provide optimal treatment. Methods that can detect and then increase the truthfulness of information are relatively unknown. To investigate the impact of communication about privacy, benefits, and risk on patient truthfulness, the investigators...
What is the current status of trial NCT04803448?
This trial is currently completed. It is a NA study. The enrollment target is 619 participants. The study started on 2020-02-12. Estimated completion is 2020-04-19.
What interventions are being tested in trial NCT04803448?
The interventions under investigation include: Benefit statement (BEHAVIORAL), Risk Statement (BEHAVIORAL), Privacy Statement (BEHAVIORAL), Benefit + Privacy (BEHAVIORAL), Risk + Privacy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04803448?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04803448's enrollment target sits among peer trials
619 161st of 2000 higher than 1,840 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02282969 · 620 participants
PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing
- NCT02838836 · 620 participants
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
- NCT05538910 · 620 participants · NA
Defining Neurobiological Links Between Substance Use and Mental Illness
- NCT05822466 · 620 participants · NA
Virtual Tai ji Quan Exercise to Prevent Falls in Older Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI